← back to search

Helen Nadel

Palo Alto University · US
Area of research
Radiology, Nuclear Medicine and Imaging · Neurology
Research interest
Research interests include Medicine, Medical physics, Nuclear medicine, Internal medicine, Neuroblastoma, and Oncology.
h-index
citations
743
works
11
NIH funding
primary concept
email

Recent publications

2024 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical Activities
Journal of Nuclear Medicine Technology 2025cited by 97position: middledoi
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global Initiative
Journal of Nuclear Medicine 2025cited by 25position: middledoi
Joint EANM/SNMMI procedural guideline for paediatric bone hybrid imaging with 99mTc-labelled radiopharmaceuticals and [18F]fluoride
EANM Innovation 2025cited by 1position: middledoi
Abstract B012: KinLET: A phase I dose-finding, safety and pharmacokinetic trial of [177Lu]Lu-edotreotide for the treatment of somatostatin receptor positive tumors in the pediatric population aged 2 to less than 18 years old
Cancer Research 2025cited by 0position: middledoi
The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy
European Journal of Nuclear Medicine and Molecular Imaging 2023cited by 22position: middledoi
SNMMI procedure standard/EANM practice guideline on pediatric [99mTc]Tc-DMSA renal cortical scintigraphy: an update
Clinical and Translational Imaging 2022cited by 44position: middledoi
ACR Appropriateness Criteria® Osteomyelitis or Septic Arthritis-Child (Excluding Axial Skeleton)
Journal of the American College of Radiology 2022cited by 19position: middledoi
Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials
European Journal of Nuclear Medicine and Molecular Imaging 2017cited by 85position: middledoi
Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children’s Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1
Journal of Nuclear Medicine 2017cited by 79position: middledoi
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment
Annals of Oncology 2014cited by 332position: middledoi
Combined PET/MR: Where Are We Now? Summary Report of the Second International Workshop on PET/MR Imaging April 8–12, 2013, Tubingen, Germany
Molecular Imaging and Biology 2014cited by 39position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2017–2025)Reza Vali · Hospital for Sick Children4 papers (2022–2025)Barry L. Shulkin · Society of Nuclear Medicine and Molecular Imaging4 papers (2017–2025) · 4 papers (2017–2025)Ruth Lim · Yale New Haven Hospital3 papers (2022–2025) · 3 papers (2022–2025)Marguerite T. Parisi · Seattle Children's Hospital3 papers (2017–2025)Pietro Zucchetta · University of Padua3 papers (2022–2025) · 3 papers (2022–2025)Bieke Lambert · Ghent University Hospital2 papers (2017–2017)Dominique Valteau‐Couanet · Université Paris-Sud2 papers (2017–2017)Julie R. Park · University of Tennessee at Knoxville2 papers (2017–2017)Katherine K. Matthay · University of California System2 papers (2017–2017)Susan G. Kreissman · University of Illinois Chicago2 papers (2017–2017)Victor J. Seghers · Texas Children's Hospital2 papers (2022–2025) · 2 papers (2022–2023) · 2 papers (2017–2017) · 2 papers (2023–2025)Ariane Boubaker · University of Lausanne2 papers (2017–2017)Lisa J. States · UC San Diego Health System2 papers (2025–2025)